Karuna Therapeutics, Inc. Profile Avatar - Palmy Investing

Karuna Therapeutics, Inc.

Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic rece…

Biotechnology
US, Boston [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of KRTX's Analysis
CIK: 1771917 CUSIP: 48576A100 ISIN: US48576A1007 LEI: - UEI: -
Secondary Listings
KRTX has no secondary listings inside our databases.